Announcements Trials
Browse Landscape

Status

Completed 28Unknown 15Recruiting 10Active not recruiting 5Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 218Observational 2

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Head and Neck Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Blood Specimen Collection 27Surveys and Questionnaires 24Magnetic Resonance Spectroscopy 10Observation 7Flow Cytometry 7Specimen Handling 6Amplified Fragment Length Polymorphism Analysis 6exemestane 5Radiotherapy 5Magnetic Resonance Imaging 5Immunoenzyme Techniques 5Biopsy 5Radiation 4Neoadjuvant Therapy 4Mental Status and Dementia Tests 4Genetic Testing 4Gene Expression Profiling 4Electroporation 4Data Collection 4Bevacizumab 4Trastuzumab 3Tomography, X-Ray Computed 3Tomography, Optical Coherence 3Therapeutics 3Surgical Procedures, Operative 3Sunitinib 3Sorafenib 3Registries 3Radiosurgery 3Psychiatric Rehabilitation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Observational × Nivolumab × Clear all
NCT06421311 2025-06-05

URADJ

Bristol-Myers Squibb

Terminated
176 enrolled
Genitourinary

Carcinoma, Transitional Cell

NCT03539198 2024-11-14

Study of Proton SBRT and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer

Mayo Clinic

Terminated
19 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡